A review of bismuth‐based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy

Abstract

About 50% of cancer patients receive radiation therapy. Despite the therapeutic benefits of this method, the toxicity of radiation in the normal tissues is unavoidable To improve the quality of radiation therapy, in addition to other methods such as IMRT, IGRT, and high radiation dose, nanoparticles have shown excellent potential when ionising radiation is applied to the target volume. Recently, bismuth-based nanoparticles (BiNPs) have become particularly popular in radiation therapy due to their high atomic numbers (Z), high X-ray attenuation coefficient, low toxicity, and low cost. Moreover, it is easy to synthesise in a variety of sizes and shapes. This study aimed to review the effects of the bismuth-based NP and its combination with other compounds, and their potential synergies in radiotherapy, discussed based on their physical, chemical, and biological interactions. Targeted and non-targeted bismuth-based NPs used in radiotherapy as radiosensitizers and dose enhancement effects are described. The results reported in the literature were categorised into various groups. Also, this review has highlighted the importance of bismuth-based NPs in different forms of cancer treatment to find the highest efficiency for applying them as a suitable candidate for various cancer therapy and future clinical applications. K E Y W O R D S nanomedicine, nanoparticles, radiation therapy | INTRODUCTIONCancer is one of the important leading causes of death worldwide. By 2030, it is estimated that there will be approximately 22 million new cases of cancer worldwide and 13 million deaths from cancer [1,2]. Clinically, the most common cancer treatments include surgery, chemotherapy, and radiation therapy, which are the main non-invasive treatments for many of these types [3]. For this purpose, radiotherapy uses ionising radiation, but unfortunately, due to hypoxia, tumour cells are more resistant to radiation than normal cells. This can lead to treatment failure and can also cause side effects in normal tissues [4]. Hence, the use of radiosensitizers may be beneficial to enhance the delivery of radiation doses to tumour cells [5].Recently, as a new radiosensitising technique in medicine, nanoparticles (NPs) may have improved the treatment of various types of tumours [6]. Therefore, many studies are limited to in vitro and in vivo conditions of nanoparticle application in radiotherapy [7,8]. However, the selection of NPs as radiosensitizers is difficult. Bismuth nanoparticles (BiNPs) with specific properties such as high atomic numbers (Z), high X-ray attenuation coefficient, low toxicity, and low cost can be used as radiosensitizers to increase uptake by many cancer cells and increase absorption of radiation in synergistic cancer therapy [9]. It is also important to note that bismuthThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Bismuth selenide nanoparticles enhance radiation sensitivity in colon cancer cells in-vitro

“…Bi2Se3 NPs have been identified as a promising tool to enhance the efficacy of radiation therapy in treating colon cancer [ 29 ]. This discovery has been reported in several scientific articles, which have discussed the potential benefits of using Bi2Se3 NPs to increase the radiosensitivity of colon cancer cells.…”

Radioprotective Effect of Selenium Nanoparticles: A Mini Review

“…Nanoparticles have various applications in medicine, such as enhancing radiation sensitivity and protection, improving diagnostic imaging, treating cancer, and delivering drugs [19][20][21][22]. Selenium nanoparticles (SeNPs) are of particular interest for their possible protective properties [23,24].…”